Redx Pharma is a drug discovery and development company formed in September 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in two main areas, cancer and infectious disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.
Redx Pharma has two subsidiaries: Redx Oncology Ltd launched in April 2012 and Redx Anti-Infectives Ltd launched in April 2013.

Type
Public
HQ
Liverpool, GB
Founded
2010
Size (employees)
145 (est)
Redx Pharma was founded in 2010 and is headquartered in Liverpool, GB
Report incorrect company information

Redx Pharma Office Locations

Redx Pharma has offices in Liverpool and Cheshire East
Liverpool, GB (HQ)
Daulby St
Cheshire East, GB
Alderley Park
Show all (2)
Report incorrect company information

Redx Pharma Financials and Metrics

Redx Pharma Financials

Redx Pharma's revenue was reported to be £30.47 m in FY, 2017
GBP

Revenue (FY, 2017)

30.5 m

Net income (FY, 2017)

1.5 m

EBITDA (FY, 2017)

2.3 m

EBIT (FY, 2017)

2 m

Market capitalization (24-May-2017)

30.3 m

Closing share price (24-May-2017)

0.3

Cash (30-Sep-2017)

23.8 m
Redx Pharma's current market capitalization is £30.3 m.
GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.3 m30.5 m

Operating expense total

4.9 m28.5 m

EBITDA

(3.5 m)(9.2 m)(14.7 m)2.3 m

EBITDA margin, %

(272%)8%
GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(3.4 m)(3.4 m)(8.2 m)(15.5 m)1.5 m

Cash From Operating Activities

(3.9 m)(2.2 m)(6.5 m)(12.5 m)14.1 m

Cash From Financing Activities

5.2 m4.1 m13.4 m9.3 m4 m

Net Change in Cash

968.1 k1.9 m6.5 m(3.7 m)18 m
GBPY, 2017

Revenue/Employee

210.2 k

Financial Leverage

1.9 x
Show all financial metrics
Report incorrect company information